Comparison of outcomes following subcutaneous or intravenous alemtuzumab administered prior to reduced intensity conditioning for transplantation in pediatric sickle cell disease.
Saved in:
| Title: | Comparison of outcomes following subcutaneous or intravenous alemtuzumab administered prior to reduced intensity conditioning for transplantation in pediatric sickle cell disease. |
|---|---|
| Authors: | Plavsa A; Department of Pediatrics, Creighton University School of Medicine, Phoenix, AZ, USA., Suresh T; Department of Pediatrics, Washington University School of Medicine, St. Louis, MO, United States of America., Dalal S; Department of Pediatrics, Washington University School of Medicine, St. Louis, MO, United States of America., Mirea L; Center for Cancer and Blood Disorders, Phoenix Children's Hospital, Phoenix, AZ, USA., Adams RH; Center for Cancer and Blood Disorders, Phoenix Children's Hospital, Phoenix, AZ, USA., Shenoy S; Department of Pediatrics, Washington University School of Medicine, St. Louis, MO, United States of America., Ngwube A; Department of Pediatrics, Creighton University School of Medicine, Phoenix, AZ, USA; Center for Cancer and Blood Disorders, Phoenix Children's Hospital, Phoenix, AZ, USA. Electronic address: axngwube@texaschildrens.org. |
| Source: | Transplant immunology [Transpl Immunol] 2025 Mar; Vol. 89, pp. 102179. Date of Electronic Publication: 2025 Feb 02. |
| Publication Type: | Journal Article; Comparative Study; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9309923 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-5492 (Electronic) Linking ISSN: 09663274 NLM ISO Abbreviation: Transpl Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39904467 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Comparison of outcomes following subcutaneous or intravenous alemtuzumab administered prior to reduced intensity conditioning for transplantation in pediatric sickle cell disease. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Plavsa+A%22">Plavsa A</searchLink>; Department of Pediatrics, Creighton University School of Medicine, Phoenix, AZ, USA.<br /><searchLink fieldCode="AU" term="%22Suresh+T%22">Suresh T</searchLink>; Department of Pediatrics, Washington University School of Medicine, St. Louis, MO, United States of America.<br /><searchLink fieldCode="AU" term="%22Dalal+S%22">Dalal S</searchLink>; Department of Pediatrics, Washington University School of Medicine, St. Louis, MO, United States of America.<br /><searchLink fieldCode="AU" term="%22Mirea+L%22">Mirea L</searchLink>; Center for Cancer and Blood Disorders, Phoenix Children's Hospital, Phoenix, AZ, USA.<br /><searchLink fieldCode="AU" term="%22Adams+RH%22">Adams RH</searchLink>; Center for Cancer and Blood Disorders, Phoenix Children's Hospital, Phoenix, AZ, USA.<br /><searchLink fieldCode="AU" term="%22Shenoy+S%22">Shenoy S</searchLink>; Department of Pediatrics, Washington University School of Medicine, St. Louis, MO, United States of America.<br /><searchLink fieldCode="AU" term="%22Ngwube+A%22">Ngwube A</searchLink>; Department of Pediatrics, Creighton University School of Medicine, Phoenix, AZ, USA; Center for Cancer and Blood Disorders, Phoenix Children's Hospital, Phoenix, AZ, USA. Electronic address: axngwube@texaschildrens.org. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229309923%22">Transplant immunology</searchLink> [Transpl Immunol] 2025 Mar; Vol. 89, pp. 102179. <i>Date of Electronic Publication: </i>2025 Feb 02. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Comparative Study; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>9309923 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1878-5492 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209663274%22">09663274 </searchLink><i>NLM ISO Abbreviation: </i>Transpl Immunol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39904467 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.trim.2025.102179 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 102179 Titles: – TitleFull: Comparison of outcomes following subcutaneous or intravenous alemtuzumab administered prior to reduced intensity conditioning for transplantation in pediatric sickle cell disease. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Plavsa A – PersonEntity: Name: NameFull: Suresh T – PersonEntity: Name: NameFull: Dalal S – PersonEntity: Name: NameFull: Mirea L – PersonEntity: Name: NameFull: Adams RH – PersonEntity: Name: NameFull: Shenoy S – PersonEntity: Name: NameFull: Ngwube A IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 03 Text: 2025 Mar Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1878-5492 Numbering: – Type: volume Value: 89 Titles: – TitleFull: Transplant immunology Type: main |
| ResultId | 1 |
